MarkAndrewLewisMD

Assistant Professor, MD Anderson Cancer Center

Dr. Lewis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2009 - 2012
Baylor Coll Med-Houston2008 - 2009
Baylor College of MedicineResidency, Internal Medicine, 2006 - 2008
Baylor College of MedicineInternship, Internal Medicine, 2005 - 2006
Baylor College of MedicineClass of 2005
Rice UniversityBA, Biology & Ancient Mediterranean Civilizations, Summa Cum Laude, 1997 - 2001

Keynote addressee, The Methodist Hospital residency & fellowship commencement 2012
Edward C. Rosenow Outstanding Trainee Teaching Award 2011-2012, 2012
Dr. Tow Tan Humanism in Medicine award 2011-2012, 2012
Mayo Hematology/Oncology Chief Fellow 2011-2012, 2012
Baylor Internal Medicine Chief Resident 2008-2009, 2009
Henry D. McIntosh Award for Outstanding Resident in Medicine 2008
Harry & Rose Caplovitz Award for Outstanding Senior Student in Internal Medicine 2005
L. Leighton Hill Award for Excellence in Pediatrics 2005
Presidential scholarships for 2001-2002, 2002-2003, 2003-2004, & 2004-2005 2005
Inductee, Beta of Texas chapter of Alpha Omega Alpha 2004
High Honors for exceptional performance in the basic sciences 2003
Named Honorary Texan by Governor Rick Perry 2002
Instructor in Medicine and Oncology Mayo Clinic College of Medicine
Board of Directors American Multiple Endocrine Neoplasia Support
Travel Award International Association of Endocrine Surgeons
Recipient Medical Oncology Small Grant for “Analysis of Recurrence Patterns in Esophageal Adenocarcinoma"
Join now to see all

PubMed

Journal Articles

Treatment of Neuroendocrine Liver Metastases.
Lewis MA, Hobday TJ, International Journal of Hepatology. 2012: 973946
Adverse Prognostic Impact of Intratumor Heterogeneous HER2 Gene Amplification in Patients With Esophageal Adenocarcinoma.
Yoon HH, Shi Q, Sukov WR, Lewis MA, Sattler CA, Wiktor AE, Wu TT, Diasio RB, Jenkins RB, Sinicrope FA, Journal of Clinical Oncology
Treatment of Liver-Limited Disease from Colorectal Cancer.
Lewis MA, Hubbard J, Interventional Oncology
Diagnosis: Nerves or Something Worse?
Sanders L, New York Times. Magazine
Intravascular Mucinosis, a Rare Cause of Cerebral Infarction.
Bernardo MC, Radford JG, Menke J, Hallemeier C, Boes CJ, Lewis M, Scheithauer B, Giannini C, Acta Neuropathologica; 121(6):785-8
Talactoferrin Immunotherapy in Metastatic Renal Cell Carcinoma: A Case Series of Four Long-Term Survivors.
Lewis M, Hayes T, Journal of Clinical Medicine Research;3(1):47-51
Opsoclonus as a suspected paraneoplastic syndrome of endometrial cancer.
Lewis M, Hartmann L, LaChance D, Jimenez R, Rare Tumors 2(3):e42
Ockham’s Razor Is Not So Sharp.
Lewis M, Agusala K, Raizen Y, Infectious Disease Reports. Vol. 2, No. 2
Join now to see all

Abstracts/Posters

Cutaneous Vasculitis Associated with All-Trans Retinoic Acid (ATRA) Therapy for Acute Promyelocytic Leukemia.
Storan E, Lewis MA, Al-Kali A, European Academy of Dermatology and Venereology Annual Meeting
Post-recurrence survival in patients with previously resected esophageal adenocarcinoma (EAC).
Lewis MA, Yoon HH, Shi Q, Diasio RB, Sinicrope FA, ASCO Annual Meeting. Abstract #95558
Preoperative Assessment of the MEN 1 Pancreas.
Lewis M, Young WF, Thompson GB, World Journal of Surgery 35: 2011 (suppl 1; abstr 0895)
Association of body mass index (BMI) with smoking and prognosis in 721 patients with esophagogastric adenocarcinoma.
Lewis MA, Shi Q, Khan M, Cassivi SD, Diasio RB, Sinicrope F, Yoon HH, 2011 ASCO Annual Meeting. Journal of Clinical Oncology 29
Hospitalization after hepatic artery embolization (HAE) for neuroendocrine tumors (NET).
Jaramillo S, Lewis MA, Roberts LR, Rubin J, Grothey A, 2011 ASCO Annual Meeting. Journal of Clinical Oncology 29
8p11.12 Myeloproliferative Syndrome: A Case Report & Brief Review of the Literature.
Yellapragada S, Mims M, Jackson C, Lewis MA, Udden M, 2008 ASH Annual Meeting. Blood (ASH Annual Meeting Abstracts)
Join now to see all

Lectures

Talactoferrin as a novel therapeutic agent in metastatic renal cell carcinoma.
2007 Texas Society of Medical Oncology meeting, Houston, Texas
Oral talactoferrin (recombinant human lactoferrin) as a novel therapeutic agent in metastatic renal cell carcinoma.
2nd place in Clinical Research at 2008 Baylor College of Medicine Housestaff Research Symposium, TX

Age 45 Is the New 50 for Colon Cancer ScreeningSeptember 1st, 2021
Should There Be Universal Molecular Testing for All Patients with Gastrointestinal Cancer?July 23rd, 2021
Survey of Cancer Care Providers' Attitude Toward Care for Older Adults with Cancer During the COVID-19 PandemicOctober 5th, 2020
Join now to see all